RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Progesterone

Prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women, Treatment of secondary amenorrhea

Indications

  • Prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women
  • Treatment of secondary amenorrhea

Adult dosing

  • endometrial hyperplasia: dose: 200; unit: mg; route: PO; interval: daily at bedtime for 12 days per 28-day cycle; fixed: true; labelExcerpt: PROMETRIUM Capsules should be given as a single daily dose at bedtime, 200 mg orally for 12 days sequentially per 28-day cycle, to a postmenopausal woman with a uterus who is receiving daily conjugated estrogens tablets.
  • secondary amenorrhea: dose: 400; unit: mg; route: PO; interval: daily at bedtime for 10 days; fixed: true; labelExcerpt: PROMETRIUM Capsules may be given as a single daily dose of 400 mg at bedtime for 10 days.

Pediatric dosing

  • Consult pharmacy/current label

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Consult pharmacy/current label

Contraindications

  • Peanut allergy
  • Abnormal genital bleeding
  • Breast cancer
  • Active DVT/PE
  • Active arterial thromboembolic disease

Clinical pearls

  • Take at bedtime; if difficulty swallowing, take with water while standing.
  • Contains peanut oil; contraindicated in patients with peanut allergy.
  • Concomitant food ingestion increases bioavailability.
  • Discontinue immediately if thromboembolic events (PE, DVT, stroke, MI) occur.

Source and review

  • DailyMed label (progesterone, Prometrium), Set ID 1cf237ff-c4f8-4faa-a7aa-77599c856889, effective 2026-07-23. Last reviewed: 2026-11-11